Article

Methotrexate Sodium–Associated UV Reactivation in a Patient With Acute Lymphoblastic Leukemia

Author and Disclosure Information

UV reactivation is an uncommon reaction characterized by recurrent inflammation in areas of prior sunburn or UV exposure following the administration of a triggering drug. We report a case of UV reactivation following administration of intravenous methotrexate sodium (MTX) 4 days after prolonged sun exposure in a 9-year-old boy with relapsed acute lymphoblastic leukemia. Our patient’s MTX-associated UV reactivation occurred despite the use of sunscreen and without prior sunburn or sun-induced erythema, which suggests that even subclinical sun damage can trigger MTX-associated UV reactivation. Therefore, patients must be strongly encouraged to utilize a 3-pronged approach to sun safety including sun avoidance, sun-protective clothing, and broad-spectrum sunscreen use, especially during the week before MTX therapy.


 

Recommended Reading

Economic Forecast: Rough Road Ahead for Dermatologists
MDedge Dermatology
Topical Hyaluronic Acid Is Breaking Through Dermis
MDedge Dermatology
Skin of Color: Cosmeceutical Lightening Agents
MDedge Dermatology
Foot-Pedal Device May Ease Filler Injections
MDedge Dermatology
Promising New Cellulite Therapies Target Fibrous Septae
MDedge Dermatology
Skin of Color: Ethnic Differences in Skin Architecture
MDedge Dermatology
Indocyanine Green-Augmented Laser Therapy Is Shrinking Vessels
MDedge Dermatology
Botanicals on Par With Hydroquinone for Treating Melasma
MDedge Dermatology
Topical Botulinum Toxin Will Turn Market 'Upside Down'
MDedge Dermatology
Fees for Cosmetic Procedures Down Since 2008
MDedge Dermatology